August 31, 2026, (Inside AI) — Shanghai Enflame Technology Co priced its Shanghai initial public offering at 142.18 yuan per share, targeting 6.1 billion yuan ($907.78 million) in proceeds. The Tencent-backed AI chipmaker will sell 43 million shares on the STAR Market, with investor subscriptions opening Wednesday.
The listing marks another milestone in China's push for semiconductor self-reliance. Washington's export controls on advanced chips have forced domestic firms to accelerate local alternatives. Enflame joins rivals Moore Threads Technology, MetaX Integrated Circuits, and Shanghai Biren Technology, all of which went public in the past year.
Enflame remains unprofitable. Its IPO pricing values the company at 61.8 times its 2025 sales, according to an exchange filing. That is far below the 160-plus multiple for listed peers Moore Threads and MetaX, but more than double Nvidia's 25.4 times 2025 sales.
The valuation gap raises questions about investor appetite for loss-making AI chipmakers. Enflame's lower multiple may reflect its revenue concentration risk. Tencent is both a major shareholder and its largest customer, creating dependency that could worry public market investors.
The eight-year-old startup aims to break Nvidia's dominance in China's AI chip market. Proceeds will fund production of fifth- and sixth-generation AI chips, plus advanced AI software and hardware projects. The offering slightly exceeds its original 6 billion yuan target.
China's Chip IPO Wave Tests Investor Patience
Enflame's debut caps a frenzied year for Chinese AI chip listings. Moore Threads, MetaX, and Biren all tapped public markets as Beijing prioritized domestic silicon. The STAR Market has become the preferred venue for these technology listings, offering faster approvals and higher valuations than traditional boards.
Yet the sector's profitability remains elusive. Enflame's 61.8 times sales multiple assumes aggressive revenue growth. Nvidia's 25.4 times multiple reflects its established dominance and consistent profits. Chinese rivals trade at 160 times sales or more, suggesting investors are betting on policy support rather than current fundamentals.
Export controls have accelerated demand for domestic AI chips. U.S. restrictions on high-end GPUs have forced Chinese cloud providers and tech giants to seek alternatives. Enflame's relationship with Tencent provides a stable revenue base, but scaling beyond its anchor customer remains a key challenge.
Revenue Concentration Casts Shadow Over Growth Story
Enflame's dependence on Tencent cuts both ways. The tech giant's backing lends credibility and provides guaranteed demand. However, investors may question whether Enflame can win orders from other hyperscalers like Alibaba or Baidu, which are also developing in-house AI chips.
The company's fifth- and sixth-generation chips will face intense competition. Moore Threads and Biren are racing to launch comparable products. MetaX focuses on inference chips, a different segment. Enflame's training-focused architecture targets Nvidia's A100 and H100 equivalents, a technically demanding market.
China's AI chip sector faces manufacturing constraints too. SMIC, the country's leading foundry, cannot produce chips on par with TSMC's advanced nodes due to U.S. equipment bans. This limits performance ceilings for domestic designs, potentially capping Enflame's long-term competitiveness against Nvidia's latest offerings.
Enflame's IPO will test whether public markets can absorb another loss-making AI chipmaker. The offering's pricing below peer multiples suggests some caution. Investors must weigh Beijing's policy support against execution risks and a concentrated customer base.
